» Articles » PMID: 31428157

Protein Kinases and Their Inhibitors in Pluripotent Stem Cell Fate Regulation

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2019 Aug 21
PMID 31428157
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Protein kinases modulate the reversible postmodifications of substrate proteins to their phosphorylated forms as an essential process in regulating intracellular signaling transduction cascades. Moreover, phosphorylation has recently been shown to tightly control the regulatory network of kinases responsible for the induction and maintenance of pluripotency, defined as the particular ability to differentiate pluripotent stem cells (PSCs) into every cell type in the adult body. In particular, emerging evidence indicates that the balance between the self-renewal and differentiation of PSCs is regulated by the small molecules that modulate kinase signaling pathways. Furthermore, new reprogramming technologies have been developed using kinase modulators, which have provided novel insight of the mechanisms underlying the kinase regulatory networks involved in the generation of induced pluripotent stem cells (iPSCs). In this review, we highlight the recent progress made in defining the roles of protein kinase signaling pathways and their small molecule modulators in regulating the pluripotent states, self-renewal, reprogramming process, and lineage differentiation of PSCs.

Citing Articles

Integrated multi-omics analysis identifies features that predict human pluripotent stem cell-derived progenitor differentiation to cardiomyocytes.

Simmons A, Baumann C, Zhang X, Kamp T, De La Fuente R, Palecek S J Mol Cell Cardiol. 2024; 196:52-70.

PMID: 39222876 PMC: 11534572. DOI: 10.1016/j.yjmcc.2024.08.007.


Establishment of porcine embryonic stem cells in simplified serum free media and feeder free expansion.

Choi H, Oh D, Kim M, Jawad A, Zheng H, Cai L Stem Cell Res Ther. 2024; 15(1):245.

PMID: 39113095 PMC: 11304784. DOI: 10.1186/s13287-024-03858-2.


Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.

Pazzin D, Previato T, Goncalves J, Zanirati G, Xavier F, Da Costa J Cells. 2024; 13(9.

PMID: 38727281 PMC: 11083827. DOI: 10.3390/cells13090745.


Cell Reprogramming and Differentiation Utilizing Messenger RNA for Regenerative Medicine.

Inagaki M J Dev Biol. 2024; 12(1).

PMID: 38535481 PMC: 10971469. DOI: 10.3390/jdb12010001.


Partial cellular reprogramming: A deep dive into an emerging rejuvenation technology.

Paine P, Nguyen A, Ocampo A Aging Cell. 2023; 23(2):e14039.

PMID: 38040663 PMC: 10861195. DOI: 10.1111/acel.14039.


References
1.
Burdon T, Stracey C, Chambers I, Nichols J, Smith A . Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol. 1999; 210(1):30-43. DOI: 10.1006/dbio.1999.9265. View

2.
Cohen P . The origins of protein phosphorylation. Nat Cell Biol. 2002; 4(5):E127-30. DOI: 10.1038/ncb0502-e127. View

3.
Ong S, Blagoev B, Kratchmarova I, Kristensen D, Steen H, Pandey A . Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002; 1(5):376-86. DOI: 10.1074/mcp.m200025-mcp200. View

4.
Riento K, Ridley A . Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003; 4(6):446-56. DOI: 10.1038/nrm1128. View

5.
Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou A . Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med. 2004; 10(1):55-63. DOI: 10.1038/nm979. View